Skip navigation

Integrating Novel Technologies, Strategies & Cross-Functional Approaches to Accelerate Development & Compress Timelines

October 17-18, 2018
  • San Francisco, CA

Nicholas Angell, PhD
Director of Process Development Attribute Sciences
Amgen Inc.

Nicole A. Bleckwenn, PhD
Associate Director, Cell Culture and
Fermentation Sciences – Tech Transfer
MedImmune, LLC.

Jie Chen, MD, MS
Vice President, CMC Management
WuXi Biologics

Yanhuai (Richard) Ding, PhD
Director, Downstream Process Development and
Manufacturing Operations
Anaptysbio, Inc.

Zorica Dragic
Team Head, Cell Line Development
Novartis

James Dvornicky
Engineer II – Purification Development
Genentech, Inc.

Mark Emalfarb
Chief Executive Officer
Dyadic International Inc.

Bert Frohlich, PhD
Principal Consultant & Owner
BioPharm Designs, LLC

Dan Garcia
Senior Director, Business Management – Bioprocess Sciences
Patheon

Robert C. Heckathorn, PhD
Associate Director,
R&D for BPD Informatics and Software Engineering
MedImmune, LLC.

Gene W. Lee, PhD
Senior Director and US Site Head of Discovery Technologies,
Protein and Cell Sciences
EMD Serono Inc

Barry Morse
Principal Research Scientist
Janssen Research & Development, LLC

Sheldon Oppenheim, PhD
Associate Engineering Fellow
Takeda

Mark Panek, PhD
Principal Scientist – Large Molecule Method Development
Janssen Research & Development LLC.

Dot Reilly, MS
Technical Development Leader
Genentech, Inc.

Santosh Thakkar, PhD
Senior Scientist – Large Molecule Drug Product Development
Janssen Research & Development LLC.

Jens H. Vogel, PhD
President & CEO
Boehringer Ingelheim Fremont Inc.

Greg Zarbis-Papastoitsis
Vice President, Process & Manufacturing
Compass Therapeutics LLC

Nicholas Angell, PhD
Director of Process Development Attribute Sciences
Amgen Inc.

Nicole A. Bleckwenn, PhD
Associate Director, Cell Culture and
Fermentation Sciences – Tech Transfer
MedImmune, LLC.

Jie Chen, MD, MS
Vice President, CMC Management
WuXi Biologics

Yanhuai (Richard) Ding, PhD
Director, Downstream Process Development and
Manufacturing Operations
Anaptysbio, Inc.

Zorica Dragic
Team Head, Cell Line Development
Novartis

James Dvornicky
Engineer II – Purification Development
Genentech, Inc.

Mark Emalfarb
Chief Executive Officer
Dyadic International Inc.

Bert Frohlich, PhD
Principal Consultant & Owner
BioPharm Designs, LLC

Dan Garcia
Senior Director, Business Management – Bioprocess Sciences
Patheon

Robert C. Heckathorn, PhD
Associate Director,
R&D for BPD Informatics and Software Engineering
MedImmune, LLC.

Gene W. Lee, PhD
Senior Director and US Site Head of Discovery Technologies,
Protein and Cell Sciences
EMD Serono Inc

Barry Morse
Principal Research Scientist
Janssen Research & Development, LLC

Sheldon Oppenheim, PhD
Associate Engineering Fellow
Takeda

Mark Panek, PhD
Principal Scientist – Large Molecule Method Development
Janssen Research & Development LLC.

Dot Reilly, MS
Technical Development Leader
Genentech, Inc.

Santosh Thakkar, PhD
Senior Scientist – Large Molecule Drug Product Development
Janssen Research & Development LLC.

Jens H. Vogel, PhD
President & CEO
Boehringer Ingelheim Fremont Inc.

Greg Zarbis-Papastoitsis
Vice President, Process & Manufacturing
Compass Therapeutics LLC